XU Mei-ting,XUE Yun-li,YANG Yue. American Consumer Behavior Studies in RX-OTC Switch and the Inspirations to Our Country[J]. Chinese Journal of Pharmacovigilance, 2015, 12(1): 34-37.
[1] FDA.Regulation of Nonprescription Products.[EB/OL].(2012-12-03) [2014-04-21].http://www.fda.gov/AboutFDA/CentersOffices/Offi-ceofMedicalProductsandTobacco/CDER/ucm093452.htm. [2] FDA.Over-the-counter (OTC) drugs.[EB/OL].(2012-10-23) [2014-05-22].http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/default.htm. [3] FDA.Regulation of nonprescription drug products[EB/OL].(2013-03-16) [2014-05-22].http://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm-148055.pdf. [4] CHPA.Briefing Information on the Rx-to-OTC Switch Process.[EB/OL].(2012-10-22) [2014-05-12].http://www.chpa.org/Switch-Process.aspx. [5] FDA. Guidance for Industry Self-Selection Studies for Nonprescription Drug Products.[EB/OL].(2013-04-03) [2014-05-22].http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guida-nces/ucm272122.pdf. [6] FDA. Guidance for Industry Label Comprehension Studies for Nonp-rescription Drug Products[EB/OL].(2010-08-15)[2014-05-23].http://www.fda.gov/downloads/drugs/guidancecomplianceregula-toryinformation/guidances/ucm143834.pdf. [7] 汤韧,王晓燕.欧美非处方药消费者研究案例分析[J].中国新药杂志,2013,(22):2596-2597. [8] 汤韧,范燕.消费者研究在非处方药中的特殊作用[J].中国药物警戒,2013,10(7):447.